Natco Pharma Board Meeting Date

Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma's ₹1,279.4 Crore rights issue closed on October 22, 2026. Shares were priced at ₹750 each on a ₹2 face value.

Value

₹1,279 Cr

Product LaunchAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Natco Pharma Product Launch

Natco Pharma launches Carboplatin Injection, a Paraplatin® generic, in the U.S. market via its subsidiary. The oncology product addresses a critical U.S. supply shortage.

Other Announcement

Natco Pharma Other Announcement

Natco Pharma Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance submission.

Share Pledge

Natco Pharma Share Pledge

Promoter V.C. Nannapaneni pledged 850,000 shares of Natco Pharma, valued at ₹67.10 Crore. This pledge creation increases encumbrance on promoter shareholding.

Value

₹67.10 Cr

Fund RaiseAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Natco Pharma Fund Raise of ₹2,000 Cr

Natco Pharma shareholders approved fund raising of up to Rs. 2,000 Crore through various instruments, along with other routine AGM resolutions.

Value

₹2,000 Cr

Annual General Meeting

Natco Pharma Annual General Meeting

Natco Pharma held its 43rd Annual General Meeting on September 30, 2026. Shareholders approved all agenda items, including a fund-raising authorisation limit of Rs. 2,000 Crore.

Board Meeting DateDangee Dums Ltd DANGEE

Dangee Dums Board Meeting Date

Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.

Board Meeting DateRelic Technologies Ltd RELICTEC

Relic Technologies Board Meeting Date

Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.

Board Meeting DateEPL Ltd EPL

EPL Board Meeting Date

EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.

Board Meeting DateChemplast Sanmar Ltd CHEMPLASTS

Chemplast Sanmar Board Meeting Date

Chemplast Sanmar will meet on 4 November 2026 to approve September quarter results. The trading window stays closed until 6 November 2026.

Board Meeting DateKemistar Corporation Ltd KEMISTAR

Kemistar Corporation Board Meeting Date

Kemistar Corporation scheduled a board meeting on 6 November 2026 to consider unaudited results. Trading window remains closed until 8 November 2026.

Board Meeting DateRajasthan Cylinders & Containers Ltd RCCL

Rajasthan Cylinders & Containers Board Meeting Date

Rajasthan Cylinders & Containers intimated a board meeting on 05 November 2026 to approve unaudited results for quarter and half year ended 30 September 2026. The trading window stays closed until 07 November 2026.